mosloflavone

from Ranunculus japonicus; structure in first source

Also Known As:

4H-1-Benzopyran-4-one, 5-hydroxy-6,7-dimethoxy-2-phenyl-; 5-Hydroxy-6,7-dimethoxy-2-phenyl-4H-chromen-4-one; 5-hydroxy-6,7-dimethoxyflavone

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Ampasala, Dinakara Rao: 1 article (06/2019)
2.	Busi, Siddhardha: 1 article (06/2019)
3.	Hnamte, Sairengpuii: 1 article (06/2019)
4.	Kumavath, Ranjith N: 1 article (06/2019)
5.	Mohanty, Saswat Kumar: 1 article (06/2019)
6.	Parasuraman, Paramanantham: 1 article (06/2019)
7.	Ranganathan, Sampathkumar: 1 article (06/2019)
8.	Reddy, Dhanasekhar: 1 article (06/2019)
9.	Suchiang, Kitlangki: 1 article (06/2019)
10.	Choi, Hwa Jung: 1 article (09/2016)

1.	Virus Diseases (Viral Diseases) 09/01/2016 - "Norwogonin, oroxylin A, and mosloflavone also inhibited virus replication during the initial stage of virus infection, and they inhibited viral VP2 protein expression, thereby inhibiting viral capsid protein synthesis. "
2.	Neoplasms (Cancer) 11/10/2023 - "Our findings underscore the potential of mosloflavone as a novel dual modulator of STAT3 and P-gp, indicating it is a promising candidate for overcoming MDR in cancer treatment." 11/10/2023 - "Regarding MDR reversal potential, mosloflavone resensitized MDR cancer cells to chemotherapies by arresting cell cycle and triggering apoptosis, possibly by enhancing reactive oxygen species accumulation and reducing phospho-STAT3. "
3.	Bacterial Infections (Bacterial Infection) 06/01/2019 - "Mosloflavone also exhibited promising potential in controlling bacterial infection in Caenorhabditis elegans model system, in vivo. "

1.	Capsid Proteins (Capsid Protein)
2.	Reactive Oxygen Species (Oxygen Radicals)
3.	Proteins (Proteins, Gene)
4.	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- one
5.	norwogonin

1.	Drug Therapy (Chemotherapy)